EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Radioactive Iodine Ablation Can Reduce the Structural Recurrence Rate of Intermediate-Risk Papillary Thyroid Microcarcinoma: A Meta-Analysis

Min Zhao, Xinyu Shi, Jing Zhang, Shengming Deng iD, Yeye Zhou iD, Runze Wen, Yixing Lu, Bin Zhang iD

Computational and Mathematical Methods in Medicine · 06.09.2022 · 2022 · 1-8

DOI: 10.1155/2022/8028846 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Computational and Mathematical Methods in Medicine, erschienen am 06.09.2022. Verfasst von Min Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou 215006, China. Hauptthemen laut MEDLINE: Iodine, Thyroid Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence of papillary thyroid microcarcinoma (PTMC) has significantly increased in recent years, and the decision to use radioactive iodine (RAI) ablation in low-risk (LR) and intermediate-risk (IR) patients is controversial. The aim of this study was to evaluate whether RAI ablation can reduce the recurrence rate in LR-IR PTMC patients.

Methods

A comprehensive literature search of the PubMed, Embase, Cochrane Library, and Web of Science was conducted according to the PRISMA statement.

Results

There were 8 studies in English that fit our search strategy, and a total of 2847 patients were evaluated. The results of the meta-analysis showed RAI ablation in LR-IR PTMC patients did not reduce cancer recurrence (risk radio (RR) 0.56, 95% CI 0.19-1.70, P = 0.31 ). Nevertheless, we further performed data analysis and found that IR PTMC patients without RAI ablation had a higher rate of cancer recurrence than those who underwent RAI ablation (RR 0.23, 95% CI 0.11-0.49, P = 0.0001 ). Furthermore, patients with risk factors for lymph node metastasis (RR 0.16, 95% CI 0.06-0.42, P = 0.0002 ), microscopic extrathyroidal extension (RR 0.19, 95% CI 0.06-0.60, P = 0.005 ), and multifocality (RR 0.13, 95% CI 0.04-0.45, P = 0.001 ) in the absence of RAI ablation were more likely to have recurrence.

Conclusions

Based on our current evidence, RAI ablation can reduce the cancer recurrence rate over 5 years in IR PTMC patients, especially when patients have some risk factors, such as lymph node metastasis, microscopic extrathyroidal extension, and multifocality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IodineThyroid NeoplasmsCarcinoma, PapillaryHumansIodine RadioisotopesLymphatic MetastasisNeoplasm Recurrence, Local

Substanzen

Iodine RadioisotopesIodine

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou 215006, China.
  • Department of General Surgery, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou 215006, China.

ORCID-Profile: Shengming Deng, Yeye Zhou, Bin Zhang

Zitieren

APA

Zhao, M., Shi, X., Zhang, J., Deng, S., Zhou, Y., Wen, R., Lu, Y., & Zhang, B. (2022). Radioactive Iodine Ablation Can Reduce the Structural Recurrence Rate of Intermediate-Risk Papillary Thyroid Microcarcinoma: A Meta-Analysis. Computational and Mathematical Methods in Medicine, 2022, 1-8. https://doi.org/10.1155/2022/8028846

Vancouver

Zhao M, Shi X, Zhang J, Deng S, Zhou Y, Wen R, et al. Radioactive Iodine Ablation Can Reduce the Structural Recurrence Rate of Intermediate-Risk Papillary Thyroid Microcarcinoma: A Meta-Analysis. Computational and Mathematical Methods in Medicine. 2022;2022:1-8. doi:10.1155/2022/8028846

BibTeX
@article{Zhao2022,
  author = {Zhao, Min and Shi, Xinyu and Zhang, Jing and Deng, Shengming and Zhou, Yeye and Wen, Runze and Lu, Yixing and Zhang, Bin},
  title = {Radioactive Iodine Ablation Can Reduce the Structural Recurrence Rate of Intermediate-Risk Papillary Thyroid Microcarcinoma: A Meta-Analysis},
  journal = {Computational and Mathematical Methods in Medicine},
  year = {2022},
  volume = {2022},
  pages = {1--8},
  doi = {10.1155/2022/8028846}
}
Kostenlos starten →